DANVERS, Mass. & RALEIGH, N.C., June 14, 2023
(Newswire.com) – Carebox, a leading provider of clinical trial matching solutions, and the National Scleroderma Foundation – a 501(c)(3) charitable organization founded in1998 to advance medical research, promote disease awareness, and provide support and education to people with scleroderma – today announced the launch of a Carebox Connect experience optimized for scleroderma clinical trials.
The new web application gives patients, caregivers and healthcare professionals an easy and effective
way to search and match to scleroderma clinical trials.
Individuals can complete a short six-question questionnaire about their condition and then instantly
see which clinical trials are potentially relevant for them. They can then get connected to a trial site
for next steps.
The Carebox Connect trial database is synchronized daily with the ClinicalTrials.gov clinical trial data
maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
Applying its human-supervised AI, Carebox converts the unstructured text in ClinicalTrials.gov that
describes eligibility criteria for enrollment into a searchable index of clinical criteria for matching with
patient characteristics.
For more advanced users, full search and filtering capabilities are available. Filters can be saved for
future use. Furthermore, based on those saved filters, users can subscribe to receive Carebox
Connect notifications in their email inbox whenever new trials open (or new sites open) in a defined
distance radius from where they are located.
Access to the new web application is available from the National Scleroderma Foundation website.
“Participation in the Carebox Connect Network is core to our mission to advance medical research,
promote disease awareness, and provide support and education to people with scleroderma, their
families and support networks,” said Mary J Wheatley, adding that “Carebox’s questionnaire and matching technology quickly identifies which trials are potentially relevant for each person’s circumstance.”
“A key aspect of the Carebox Connect Network is its ability to create optimized experiences that align
with specific needs of the patient populations served by each of our partners,” Brian Weiss, Carebox
CEO, said. “We are proud to be able to support the incredibly important work of the National
Scleroderma Foundation and are committed to continuing to expand our network of partners to
reach as many patients as possible.”
A relentless force in finding a cure and improving the lives of people affected by scleroderma, the
National Scleroderma Foundation advances medical research, promotes disease awareness, and
provides support and education to people with scleroderma, their families and support networks.
Supported by a network of thousands of individuals across the United States, the Foundation is the
leading nonprofit funder of peer-reviewed research to discover the cause, understand the
mechanisms, and overcome scleroderma forever. National Scleroderma Foundation has been
recognized for its commitment to financial transparency and reporting with six consecutive years of
four-star ratings by Charity Navigator, and a platinum seal of approval by Candid. For more
information, visit scleroderma.org.
Carebox connects patients and physicians seeking treatment options with clinical trials. For patients
and families, access to information about the newest and most advanced treatment options is
obscured and frustrating to find. For pharma companies, clinical trial recruitment is the primary
bottleneck in the $100B+ drug development market now being reshaped by precision medicine
treatment specificity, new trial models, diversity requirements, and digital health consumer
expectations. Carebox is at the forefront of addressing these challenges for patients and their
families, as well as for the ecosystem of companies involved in sponsoring, running, and recruiting
for clinical trials. For more information, visit careboxhealth.com.
The Carebox Connect cloud platform digitizes Carebox’s two decades of experience in navigating
over one million patients seeking clinical trial options. It enables trial sponsors of all sizes to educate,
engage, navigate, match, qualify, refer, and enroll patients in their clinical trials. Pharma trial
sponsors, hospital research centers, and patient advocacy groups use Carebox Connect to present
their clinical trial portfolios to the public, optimize trial recruitment, and enhance participant diversity
in support of ongoing clinical research.
In addition to customer-branded Carebox Connect solutions for trials sponsors and sites, the
Carebox Connect Network brings the power of the platform to patients, families, and caregivers via a
rapidly growing network of tens of patient advocacy groups and physician associations. Carebox runs
co-branded and branded web applications and/or clinical trial navigation services on behalf of its
Carebox Connect Network partners.
The complete article is available by clicking here.
When We Tri(al) by TOUCH, The Black Breast Cancer Alliance has partnered with Carebox to provide Breasties, caregivers, and the entire Black community with an easy way to search and match to breast cancer clinical trials.
Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer clinical trials.
Clinical trials continue to experience a paucity of diversity, but it will take a multipronged approach to infuse DEI into research.
Newest Carebox Connect Clinical Trial Sponsor Website Helps Mirati Therapeutics Deliver on Its Commitment to Patient-Centricity
THANC Guide resource center for thyroid, head and neck cancer patients will now feature Carebox Connect for clinical trial search and matching.
Carebox to help LCRF advance lung cancer research by making it easier and more effective for patients, caregivers and healthcare professionals to identify relevant lung cancer trials.
Why aren’t the eligibility criteria of clinical trials searchable? The short answer is: because that’s not where the light is.
Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials.
Clinical trial websites are not providing the answer to the question that matters most to patients.
CVS Health is winding down its clinical trials business, with a full exit expected by December 31, 2024, the company confirmed to MedCity News. But decentralized clinical trials still have an important role to play, said Brian Weiss, CEO of Carebox.
An invitation to shape how patients find clinical trial treatment options.
Pilot of EHR-embedded clinical trial matching to enhance diversity in cancer research set to begin at two hospital systems in Texas and West Virginia.
Carebox Connect ™ empowers patients, families, and their physicians to find treatment options only available in clinical trials.
© Copyright 2023 by Carebox Healthcare Solutions, Inc.
We strive to answer all inquiries within one business day.
We strive to answer all inquiries within one business day.
Are you sure you would like to leave the Carebox website? If you press ‘Continue’ you will be directed to a different website. Carebox is not responsible for any content on the site you are about to visit, nor the privacy policy of that website.
Please share your feedback ideas and suggestions to help make Carebox Connect more useful to patients, doctors, trial sites, and/or trial sponsors. No idea is too small and no input is insignificant.
Your message was submitted successfully. We will get back to you within the next few days.
